81
Views
1
CrossRef citations to date
0
Altmetric
Letters to the Editor

Validation and further potentialities of the novel AWM score for progression risk stratification in patients with asymptomatic Waldenström macroglobulinemia

, , , , , , , & show all
Pages 987-989 | Received 06 Aug 2019, Accepted 23 Oct 2019, Published online: 14 Nov 2019
 

Disclosure statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

This work was funded by Fondazione Regionale Ricerca Biomedica (Milano, Italy); AIL Varese ONLUS; Fondazione Rusconi (Varese, Italy); Fondazione Matarelli (Milano, Italy).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.